ANEB vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ANEB

43.6
AI Score
VS
ANEB Wins

JBIO

32.5
AI Score

Investment Advisor Scores

ANEB

44score
Recommendation
HOLD

JBIO

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ANEB JBIO Winner
Net Income -4.16M -96.13M ANEB
Operating Income -4.88M -102.36M ANEB
ROE -52.4% -21.9% JBIO
ROA -44.1% -20.4% JBIO
Total Assets 9.42M 472.11M JBIO
Cash 9.04M 107.25M JBIO
Current Ratio 31.63 14.93 ANEB

Relative Price Performance (Last 90 Days)

ANEB 1M: -57.9% · 3M: -84.7% JBIO 1M: +18.1% · 3M: -35.8%

Current Technical Phase

ANEB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -41.2%), weak momentum, RSI 18

RSI (14): 17.7 · Price: $0.36

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.2 · Price: $15.87

Fundamentals Snapshot

Metric ANEB JBIO
Market Cap — —
Forward P/E -0.8 -6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.18 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ANEB is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.